Search research articles
Contact Us
Filters
Showing results (11-20 of 94) with videos related to
Page
of 10
Sort By:
La Revue De Medecine Interne
|
January 1, 1997
[Environmental factors and iatrogenic elements in systemic scleroderma and related syndromes. Review of the literature]
O Hallé, T Schaeverbeke, B Bannwarth, et al.
Clinical and Experimental Rheumatology
|
May 18, 2005
Lupus erythematosus manifestations exacerbated by etanercept therapy in a patient with mixed connective tissue disease
C Richez, P Blanco, C Dumoulin, et al.
British Journal of Rheumatology
|
December 1, 1994
Seronegative symmetrical polyarthritis with pitting oedema associated with antinuclear antibodies and a past history of giant cell arteritis
S Marce, T Schaeverbeke, B Bannwarth, et al.
Joint Bone Spine
|
April 28, 2001
Arthropathy associated with anti-Jo-1 antibody
X Delbrel, T Schaeverbeke, F Lifermann, et al.
Clinical and Experimental Rheumatology
|
September 19, 2008
Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature
L Lévy, B Fautrel, T Barnetche, et al.
Drugs
|
January 1, 1994
Methotrexate in rheumatoid arthritis. An update
B Bannwarth, L Labat, Y Moride, et al.
The Journal of Rheumatology
|
October 1, 1993
Is low dose methotrexate nephrotoxic?
S Marcé, B Bannwarth, T Schaeverbeke, et al.
Clinical and Experimental Rheumatology
|
October 16, 2004
Successful treatment of relapsing polychondritis with infliximab
C Richez, C Dumoulin, X Coutouly, et al.
Lancet (London, England)
|
April 20, 1991
NSAIDs, misoprostol, and gastrointestinal bleeding
B Bannwarth, T Schaeverbeke, J Dehais, et al.
Clinical Pharmacokinetics
|
March 1, 1996
Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis
B Bannwarth, F Péhourcq, T Schaeverbeke, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 94) with videos related to
Sort By:
Page
of 10
La Revue De Medecine Interne
|
January 1, 1997
[Environmental factors and iatrogenic elements in systemic scleroderma and related syndromes. Review of the literature]
O Hallé, T Schaeverbeke, B Bannwarth, et al.
Clinical and Experimental Rheumatology
|
May 18, 2005
Lupus erythematosus manifestations exacerbated by etanercept therapy in a patient with mixed connective tissue disease
C Richez, P Blanco, C Dumoulin, et al.
British Journal of Rheumatology
|
December 1, 1994
Seronegative symmetrical polyarthritis with pitting oedema associated with antinuclear antibodies and a past history of giant cell arteritis
S Marce, T Schaeverbeke, B Bannwarth, et al.
Joint Bone Spine
|
April 28, 2001
Arthropathy associated with anti-Jo-1 antibody
X Delbrel, T Schaeverbeke, F Lifermann, et al.
Clinical and Experimental Rheumatology
|
September 19, 2008
Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature
L Lévy, B Fautrel, T Barnetche, et al.
Drugs
|
January 1, 1994
Methotrexate in rheumatoid arthritis. An update
B Bannwarth, L Labat, Y Moride, et al.
The Journal of Rheumatology
|
October 1, 1993
Is low dose methotrexate nephrotoxic?
S Marcé, B Bannwarth, T Schaeverbeke, et al.
Clinical and Experimental Rheumatology
|
October 16, 2004
Successful treatment of relapsing polychondritis with infliximab
C Richez, C Dumoulin, X Coutouly, et al.
Lancet (London, England)
|
April 20, 1991
NSAIDs, misoprostol, and gastrointestinal bleeding
B Bannwarth, T Schaeverbeke, J Dehais, et al.
Clinical Pharmacokinetics
|
March 1, 1996
Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis
B Bannwarth, F Péhourcq, T Schaeverbeke, et al.
Page
of 10